Board
Screen
Heat
Cal
Watch
News
Blog
TV
Home
/
MRK
Home
/
MRK

NYSE
$148.35
$148.35

Overview

Price performance
Low
$146.05
High
$148.93
Market open. Last updated: Nov 4, 2026, 5:28 PM UTC
$
148.35
3.68 (2.54%)
Average, 50 days
$146.66
$127.07
Open
$146.79
Previous close
$144.67
52-week high
$156.92
Aug 25, 2026 (3 months ago)
52-week low
$82.91
Nov 5, 2025 (13 months ago)
78.93%

Valuation & Estimates

Earnings

Financials

Insider Trading

Peer Analysis

Insights & Activity

Market Cap
366.00B
Volume
2 930 812
Total Return (3M)
15.90%
Total Return (1Y)
76.90%
15.08
Sector
Healthcare
Links
Tags
Healthcare
Drug Manufacturers - General
NYSE
US
Website
merck.com
Socials
About
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.

Frequently asked questions

MRK · Merck & Co., Inc.

01What is Merck & Co., Inc. stock price today?

The current price of MRK is $148.35 — it has increased by 2.54% since the previous close. Data as of Nov 4, 2026.

02Is Merck & Co., Inc. stock price growing?

MRK is down 0.80% over the past week, up 2.81% over the past month and up 76.90% over the past year. The price is above its 200-day moving average of $127.07.

03What is Merck & Co., Inc. market cap?

Merck & Co., Inc. has a market capitalization of $366B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.

04How volatile is MRK stock?

In the latest trading session MRK moved between $146.05 and $148.93, a range of 1.94% of its current price.

05What are MRK stock 52-week high and low?

Over the past 52 weeks MRK has traded between $82.91 and $156.92. The current price is 5.46% below its 52-week high.

Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.